There is no shortage of debate among interventional cardiologists over whether vascular closure devices should be used ...
Vascular Closure Devices
This channel includes news and new technology innovations for vascular closure devices used to rapidly seal and achive hemostatsis at vascular access sites in interventional cardiology procedures.
Feature | Patrick Antoun, M.D., and Jeffrey A. Breall, M.D., Ph.D.
Vascular closure devices (VCD) were first introduced in the early 1990s with a goal to achieve quick hemostasis, thus ...
September 13, 2013
May 28, 2013 — The U.S. District Court for the District of New Jersey approved an agreement under which Vascular ...
May 28, 2013February 19, 2013 — CardioLogical Solutions is an emerging cardiovascular device company formed by the merger of ...
February 19, 2013
February 7, 2013 — Cardiva Medical Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Premarket ...
February 07, 2013December 10, 2012 — Vascular Closure Systems Inc. announced the successful conclusion of Phase I and Phase II of the ...
December 10, 2012
November 6, 2012 — Vascular Solutions launched the R-Band radial hemostasis compression device in the United States ...
November 06, 2012
Feature | Dave Fornell
Vascular closure devices that use an active method to immediately seal the femoral access site can enable faster patient ...
August 29, 2012
Feature | Christopher Wilson, D.O.; Kerri Wing, R.N., BSN; Peter Wassmer, M.D., FACC, and Robert Sanchez M.D., FACC
The implementation of dedicated access site surveillance and educational programs, in tandem with pre-existent ...
August 29, 2012
Feature | Dave Fornell
Due to the increasing number of transcatheter aortic valve replacements (TAVR) and endovascular aneurysm repair (EVAR) ...
August 15, 2012July 6, 2012 — Vascular Closure Systems Inc. announced that the 30-day follow-up results for the Phase I first-in-human ...
July 06, 2012
June 4, 2012 — SentreHeart Inc., a privately held medical device company, announced that it has recently completed a $26 ...
June 04, 2012May 4, 2012 - CardioDex announces initial commercial use of a new femoral access site closure device. Recent data from ...
May 04, 2012April 20, 2012 — VasoStitch will be featuring its technology at EuroPCR, Europe’s largest interventional cardiology scie ...
April 20, 2012
March 16, 2012 -- Kensey Nash Corp. today announced that the company has entered into a $39 million settlement agreement ...
March 19, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now